In-Store and Online Fundraising Campaign to Support Women Diagnosed with Breast Cancer Chico’s FAS (NYSE: CHS) kicked off its 15th consecutive fundraising campaign for Living Beyond Breast Cancer, a national nonprofit, on Sept. 1, officially launching an eight-week fundraising program that runs through October. A portion of every customer’s purchase at Chico’s®, White House Black Market® and Soma® boutiques, online …
Biomarkers for Early-Stage Invasive Breast Cancer Clinical Practice Guidelines (ASCO, 2019)
Source: American Society of Clinical Oncology From: medscape.com The American Society of Clinical Oncology (ASCO) published recommendations on the use of biomarkers for decision making regarding adjuvant systemic treatment for women with early-stage invasive breast cancer in April 2016.[1] In August 2017 and August 2019, ASCO released focused updates of these guidelines.[2,3] The combined recommendations are summarized below. ASCO advises …
Hereditary Cancer Risk Variants Found in Significant Subset of Metastatic Breast Cancer Patients
By: Staff Reporter From: genomeweb.com Investigators from Johns Hopkins University School of Medicine and the Vanderbilt Ingram Cancer Center have demonstrated that there is a potential benefit to doing widespread hereditary cancer risk testing in individuals with metastatic breast cancer. “[O]ur results provide evidence to support genetic testing for inherited cancer predisposition among all patients with metastatic breast cancer, because …
Savvy Cooperative: Multiple Paid Opportunities for Current Cancer Patients and Survivors
Savvy Cooperative is the first and only patient-owned co-op that empowers people to use their health experiences to inform new products and services through surveys, interviews, product testing and more! It was founded by two patients who wanted to make sure people who shared their health experiences were fairly compensated. That’s why we are patient-owned and the majority of our …
Novel therapy studied for inherited breast cancer
By: Will Sansom From: uthscsa.edu UT Health San Antonio researchers have discovered a novel way to kill cancers that are caused by an inherited mutation in BRCA1, the type of cancer for which actress Angelina Jolie had preventive double mastectomy and reconstructive surgery in 2013. “This represents a new treatment for inherited breast and ovarian cancer, which are higher in …
Hormone therapy during menopause raises breast cancer risk for years, study finds
By: Megan Thielking From: statnews.com A sweeping new analysis adds to the evidence that many women who take hormone therapy during menopause are more likely to develop breast cancer — and remain at higher risk of cancer for more than a decade after they stop taking the drugs. The study, published Thursday in the Lancet, looked at data from dozens …
Diverse immune cell profiles and roles found in breast cancer resistance to immunotherapy
Source: Baylor College of Medicine From: sciencedaily.com Researchers show that heterogeneity of both breast cancer cells themselves and immune composition of the tumor microenvironment are important considerations for therapy. In recent years it has been increasingly appreciated that immune cells within the tumor microenvironment contribute to tumor progression and, importantly, to the tumor’s response to therapy. To better understand the …
Moffitt Researchers Develop Model to Personalize Breast Cancer Radiation Treatment
From: itnonline.com A personalized approach to cancer treatment has become more common over the last several decades, with numerous targeted drugs approved to treat particular tumor types with specific mutations or patterns. However, this same personalized strategy has not translated to radiation therapy, and a one-size-fits-all approach for most patients is still common practice. Moffitt Cancer Center researchers hope to …
CRISPR gene editing may halt progression of triple-negative breast cancer
Source: Boston Children’s Hospital From: eurekalert.org A tumor-targeted CRISPR gene editing system, encapsulated in a nanogel and injected into the body, could effectively and safely halt the growth of triple-negative breast cancer, report researchers at Boston Children’s Hospital. Their proof-of-principle study, conducted in human tumor cells and in mice, suggests a potential genetic treatment for triple-negative breast cancer, which has …
Modified drug combination may reduce risk of recurrence for some breast cancer patients
By: Virginia Commonwealth University From: medicalxpress.com Oncologists at VCU Massey Cancer Center were invited to co-author an editorial published in the Journal of Clinical Oncology providing expert commentary on findings from a large study conducted by German investigators that a modified drug combination may lead to a decreased chance of disease recurrence for women with high risk, HER-2 negative breast …